HOME >> BIOLOGY >> NEWS
Anthrax drugs used to treat adults can treat children, too

COLUMBUS, Ohio - The two drugs most commonly used to treat anthrax in adults could cause unwanted side effects if used in children, according to an analysis of pediatric anthrax treatment options.

But the risks of using either medication pale in comparison to the risks of anthrax disease, said Milap Nahata, a professor and chair of pharmacy practice and administration at Ohio State.

"Anthrax can be fatal, and children may have the greatest risk for developing the disease in the event of a major bioterrorism attack," he said. "So the use of these antibiotics can be recommended despite the lack of adequate efficacy and safety studies in children." The researchers analyzed nearly 20 studies that examined the safety and efficacy of two medications - ciprofloxacin and doxycycline -- when used in children. The drugs are also often used to treat adults with the disease.

Past research links ciprofloxacin (or cipro) to bone deformations and doxycycline to bone growth inhibition and tooth discoloration in children.

Nahata conducted the study with Sandra Benavides, a postdoctoral fellow in pharmacy at Ohio State. Their analysis appears in a recent issue of The Annals of Pharmacology.

Anthrax infectio
'"/>

Contact: Milap Nahata
Nahata.1@osu.edu
614-292-2472
Ohio State University
22-Apr-2002


Page: 1 2 3 4

Related biology news :

1. Anthrax enzyme images reveal secrets of antibiotic resistance, suggest new drug design
2. Anthrax spores can germinate, grow and reproduce in soil
3. Anthrax research might provide more time for treatment
4. Anthrax: A soil bug gone bad
5. Anthrax threat needs aggressive government action plan, say researchers
6. CDC MMWR: Fetal Alcohol Syndrome and Cutaneous Anthrax in a Lab Worker
7. Anthrax spores use failsafe protection system, say U-M scientists
8. Anthrax genome may contain new clues to fight infection, says Science Functional Genomics article
9. Anthrax dectectors are coming
10. Anthrax - Trail of terror
11. Anthrax - How to protect ourselves

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: